Nouveau Life Pharmaceuticals, Inc. (NOUV)

NOUV Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Mar 31, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003
Cost of Revenue	-	-	-	-	-	0
Gross Profit	-	-	-	-	-	-0
Selling, General & Admin	0.16	0.16	0.18	0.27	0.16	0.18
Research & Development	-	-	-	-	0.01	-
Operating Expenses	0.41	0.27	0.18	0.27	0.23	0.18
Operating Income	-0.41	-0.27	-0.18	-0.27	-0.23	-0.18
Interest Expense	-0.08	-0.08	-0.08	-0.08	-0.08	-0.07
Currency Exchange Gain (Loss)	-0.02	-0.01	-0.01	-0	-0	-
Other Non Operating Income (Expenses)	-	-	-	-0.05	-	-0
EBT Excluding Unusual Items	-0.5	-0.36	-0.27	-0.4	-0.31	-0.25
Other Unusual Items	-	-	0.01	-	-	-
Pretax Income	-0.5	-0.36	-0.26	-0.4	-0.31	-0.25
Net Income	-0.5	-0.36	-0.26	-0.4	-0.31	-0.25
Net Income to Common	-0.5	-0.36	-0.26	-0.4	-0.31	-0.25
Shares Outstanding (Basic)	30	28	26	24	23	22
Shares Outstanding (Diluted)	30	28	26	24	23	22
Shares Change (YoY)	9.94%	9.14%	6.60%	7.74%	4.56%	3.04%
EPS (Basic)	-0.02	-0.01	-0.01	-0.02	-0.01	-0.01
EPS (Diluted)	-0.02	-0.01	-0.01	-0.02	-0.01	-0.01
Free Cash Flow	-0.02	-0.02	-0.08	-0.06	-0.08	-0.01
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EBITDA	-0.16	-0.16	-	-	-	-
D&A For EBITDA	0.24	0.11	-	-	-	-
EBIT	-0.41	-0.27	-0.18	-0.27	-0.23	-0.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.